Product Reports Resources Pricing Login Book a demo

Intermolecular

Biotech & Life Sciences · San Jose, United States · Founded 2004 · IPO 2011

Intermolecular, Inc. operates as a crucial partner in the materials innovation sector, specializing in the exploration, testing, and development of advanced materials that underpin next-generation electronics. The company was founded in 2004 by David Lazovsky, who brought extensive experience from the semiconductor equipment industry, having previously worked at Applied Materials. His background in semiconductor technology directly informed Intermolecular's approach to accelerating research and development through a combination of proprietary high-throughput combinatorial processing tools and advanced data analytics. This methodology allows for the rapid testing of a vast number of material combinations, significantly reducing the time and cost associated with bringing new materials to market. The firm's business model is centered on providing services to semiconductor and electronics manufacturers, helping them overcome complex materials challenges. Intermolecular's core offering is its High-Throughput Experimentation (HTE) platform, which integrates hardware, software, and data analytics to streamline the materials discovery process. Clients leverage this platform to accelerate their own R&D cycles, improve device performance, and secure intellectual property. Revenue is primarily generated through collaborative development programs and licensing of its technology and intellectual property. This approach positions the company as an external R&D arm for its clients, offering specialized expertise and infrastructure that might be prohibitive to develop in-house. A significant milestone in the company's history was its acquisition by Merck KGaA, Darmstadt, Germany, in 2019, for approximately $62 million. This transaction transformed Intermolecular into the Silicon Valley science hub for Merck's Performance Materials business, now part of its Electronics division. The acquisition was a strategic move by Merck to bolster its capabilities in data analytics and materials informatics, particularly for the electronics industry. For Intermolecular, becoming part of a global science and technology company provided access to greater resources and a broader market, allowing it to continue breaking boundaries in materials science while contributing to Merck's larger mission of advancing digital living. Keywords: materials innovation, semiconductor R&D, advanced materials, high-throughput experimentation, materials informatics, electronics, data analytics, combinatorial processing, materials discovery, intellectual property licensing

Valuation $0–100M
Revenue $10–50M
EBITDA $7.0M
Headcount <100
Total funding $50–100M

Investors

4 investors on Intermolecular's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 3 investors entered at this stage
Series B+ 1 investor entered at this stage
Symyx

Global footprint

Where Intermolecular has talent and traffic

Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown
Web traffic by country
170 monthly visits
across markets
🇺🇸 United States117.6%
Top 1 markets shown

Talent graph

The shape of Intermolecular's talent

Dealroom maps Intermolecular's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

34 team members profilednamed & role-tagged by Dealroom
74 employeestotal headcount
2 executives & foundersidentified by name
DimensionScore
AI Talent Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Intermolecular's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Market sentiment

What the market is saying about Intermolecular

An AI-synthesized read of the highest-engagement posts about Intermolecular on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Intermolecular on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.